<DOC>
	<DOCNO>NCT02151773</DOCNO>
	<brief_summary>The purpose survey assess safety freeze-dried live attenuate measles rubella combine vaccine ( Schwarz FF-8 strain/TO-336 strain ) ( freeze-dried live attenuate measles rubella combine vaccine `` Takeda '' ) term occurrence unknown/known adverse drug reaction factor may influence safety vaccinee first vaccination .</brief_summary>
	<brief_title>Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine ( Schwarz FF-8 Strain/TO-336 Strain ) Special Drug Use Surveillance Vaccinees After First Vaccination</brief_title>
	<detailed_description>This survey design assess safety live attenuate measles rubella combine vaccine ( Schwarz FF-8 strain/TO-336 strain ) ( freeze-dried live attenuate measles rubella combine vaccine `` Takeda '' ) term occurrence unknown/known adverse drug reaction factor may influence safety vaccinee first vaccination . Freeze-dried live attenuate measles rubella combine vaccine ( Schwarz FF-8 strain/TO-336 strain ) dissolve 0.7 mL accompany reconstitution fluid ( water injection [ Japanese Pharmacopoeia ] ) , wherein 0.5-mL portion typically administer subcutaneously single dose . In addition , freeze-dried live attenuate measles rubella combine vaccine ( Schwarz FF-8 strain/TO-336 strain ) use accordance `` Regulations Vaccination '' `` Guidelines Routine Vaccination . ''</detailed_description>
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Vaccinees meet follow condition [ 1 ] [ 2 ] : 1 . Vaccinees prior history either measles rubella vaccination receive freezedried live attenuate measles rubella combine vaccine ( Schwarz FF8 strain/TO336 strain ) initial vaccination . 2 . Vaccinees whose guardian able participate questionnaire survey health status vaccinee vaccination freezedried live attenuate measles rubella combine vaccine ( Schwarz FF8 strain/TO336 strain ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>